Flortaucipir not checked
Eli Radiopharma · ELI-101
FollowEvery change as it happens, and a Monday email
Trials
3 active
4 in total · 3 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “A radioactive diagnostic agent intended for brain positron emission tomography (PET) imaging in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD), to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs).”In the company’s words, NCT07580703 on ClinicalTrials.gov
- Tested for
- AD - Alzheimer's Disease, MCI
- Main trialPhase 1
- “This is a non randomized, open-label Phase I study in Chinese participants. The goal of this clinical trial is to evaluate the safety and tolerability of a radioactive imaging agent called \[18F\]Flortaucipir Injection, which is used during a PET scan. The study will also measure how the agent moves through the body (pharmacokinetics), where it goes (biodistribution), the amount of radiation exposure (radiation dosimetry), and how well it may help detect signs of disease (preliminary diagnostic efficacy).”In the company’s words, NCT07580703 on ClinicalTrials.gov
- Other names
- ELI-101
Coming up1
- 31 DecPhase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 31 Dec 2026 | A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy | |
| Phase 2/3Authorised | not given | The clinical value of tau PET in the memory clinic (TAP-TAU) | |
| Phase 2Authorised | not given | Tau PET imaging in cognitively normal elderly subjects: A twin approach | |
| Phase 2Ended | not given | Synaptic density and tau pathology in Alzheimer’s disease (SYNAPSE) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026